Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma

T-cell acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) are highly aggressive malignant tumors. With the current intensive treatment regimens, event-free survival (EFS) rates of up to 60–90% can be achieved, but the survival rate of relapsed patients remains poor—only approximatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hui, Du, Yuxin, Xu, Ji, Zhang, Mingzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797845/
https://www.ncbi.nlm.nih.gov/pubmed/35117001
http://dx.doi.org/10.21037/tcr.2019.10.04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797845/
https://www.ncbi.nlm.nih.gov/pubmed/35117001
http://dx.doi.org/10.21037/tcr.2019.10.04

Ejemplares similares